Reported Local News · San Diego, CA
California biotech lays off nearly all its staff after drug trial failure and 2 patient deaths
First reported
Sources
-
News Mercurynews
California biotech lays off nearly all its staff after drug trial failure and 2 patient deaths
From Mercurynews: San Diego biotech is abandoning its lead immunotherapy treatment for rheumatoid arthritis roughly five months after raising about $300 million from investors.
Read the full report on Mercurynews (opens in a new tab)
GeoDigg shows the headline and a short summary. The reporting belongs to its original publisher.
From the community
No community updates yet. Are you nearby? Add what you see.